Gamma charge-modified monoclonal antibody modification synthetic polymers Antimyosin Fab synthetic polymers DTPAs DTPA-PL agents molecular weights kD immunoreactivities modified antibodies modification procedure isoelectric points PI unmodified antimyosin AM Fab PI Mr PIs Mr kD AM-Fab preparations specific target localization visualization vivo experimental canine model acute myocardial infarction charge-modified AM-Fab preparations enhanced target necrotic myocardium visualization min intravenous infusion decreased background activity normal myocardium mean ID/g relative conventional AM-Fab equal concentration antimyosin Fab non-target organs liver kidneys diagnostic therapeutic applications charge-modified macromolecules target localization non-target organ activity 